Michael Mcbride, DO
NPI 1508325697 · Dermatology Physician · Phoenix, AZ
Enrolled with Medicare as Practitioner - Dermatology · source: CMS PECOS Public Provider Enrollment (2026.04.01)
Provider details
- NPI number
- 1508325697
- Entity type
- Individual
- Primary specialty
- Dermatology PhysicianAllopathic & Osteopathic Physicians
- Credential
- DO
- Sex
- Male
- Sole proprietor
- No
Specialties & taxonomies
Allopathic & Osteopathic Physicians
Student, Health Care
Profile Score
A profile completeness & documented-activity index — NOT a quality, outcomes, or patient-satisfaction rating.
- Registry tenure25% of score
7 yrs in NPPES registry
- Profile completeness25% of score
83% of core fields populated
- Practice footprint15% of score
4 documented practice locations
- Medicare service volume (vs. specialty peers)25% of score
2,850 Medicare services, 2024 (ranked within specialty)
- Open Payments transparency10% of score
Has Open Payments disclosures (2024)
Medicare volume is ranked against active providers in the same specialty. Signals a provider has no public data for (e.g. Medicare claims) are left out of the score entirely — never counted as zero — so providers without that data are not penalized. See the full formula and weights in our .
What this provider does (Medicare)
Based on Medicare fee-for-service claims, 2024; not all care is captured.
| Service (HCPCS) | Medicare services | Typical Medicare-allowed (2024) |
|---|---|---|
| Destruction of Precancer Skin Growth, 2-14 Growths17003 | 743 | $6 |
| Established Patient Office Or Other Outpatient Visit With Moderate Level of Decision Making, If Using Time, 30 Minutes Or More99214 | 422 | $124 |
| Biopsy of Related Skin Growth, First Growth11102 | 337 | $86 |
| Destruction of Precancer Skin Growth, 1 Growth17000 | 329 | $46 |
| Established Patient Office Or Other Outpatient Visit With Low Level OD Decision Making, If Using Time, 20 Minutes Or More99213 | 243 | $87 |
| Biopsy of Related Skin Growth, Each Additional Growth |
What this provider prescribes (Medicare Part D)
Top drugs by Medicare Part D claim volume, 2024 · 11 distinct drugs on file.
| Drug | Part D claims (2024) | Beneficiaries |
|---|---|---|
| Ketoconazole | 88 | 54 |
| Triamcinolone Acetonide | 72 | 58 |
| Hydrocortisone | 46 | 34 |
| Fluorouracil | 45 | 42 |
| Clobetasol Propionate | 38 | 32 |
| Clindamycin Phosphate | 24 | 19 |
| Doxycycline Hyclate | 23 | 15 |
| Betamethasone Dipropionate | 17 | 12 |
Transparency — industry payments
Based on CMS Open Payments, 2024; not all care is captured.
$2,424 across 122 records (Open Payments 2024)
Open Payments discloses payments and transfers of value (meals, travel, consulting, research, royalties) from drug and device makers to providers. This is a transparency signal, not a verdict — such payments are legal and common, and their presence is neither an endorsement nor a criticism. Source: CMS Open Payments, program year 2024.
Practice location
Mailing address
Additional practice locations (3)
- 2150 S Dobson Rd Ste 1Mesa, AZ 85202-6487Phone: (480) 820-9774Fax: (480) 681-3301
- 3400 E Mcdowell RdPhoenix, AZ 85008-3884Phone: (480) 681-3300Fax: (480) 681-3301
- 13843 W Meeker Blvd Ste 101Sun City West, AZ 85375-5285Phone: (623) 377-7546Fax: (480) 704-7549
Registry dates
- Enumerated
- 2019-03-18
- Last updated
- 2023-05-08
- Certified
- 2023-05-08
Source: CMS NPPES Data Dissemination (June 2026). NPI Central is not affiliated with CMS. Data is provided as-is from the public registry.